by Life Science Newswire | Dec 11, 2019 | Clinical Research & Trials, Corporate, Finance & Investor, Diagnostics & Hospital Laboratory, Pharma
Inceptua announced today that Stefan Fraenkel has been appointed CEO effective 1 January 2020. Alan Raffensperger is appointed Executive Vice-Chairman of the Inceptua Group. Inceptua – a pharmaceutical company and service partner spanning throughout the product...
by Life Science Newswire | Dec 9, 2019 | Clinical Research & Trials, Healthcare, Pharma
Onconova Therapeutics, Inc., a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), and Inceptua Medicines Access (a business unit of the Inceptua Group), a global...
by Life Science Newswire | Dec 5, 2019 | Biomanufacturing, Biotechnology, Clinical Research & Trials, Corporate, Finance & Investor, Diagnostics & Hospital Laboratory, Drug Discovery & Development, Pharma
Inceptua announced today that Paul Wituschek has been appointed President North America. To further strengthen its position as a leading pharmaceutical company and service partner, Inceptua appoints Paul Wituschek as President North America effective 1 January,...
by Life Science Newswire | Dec 3, 2019 | Analytical Chemistry, Biomanufacturing, Bioprocessing, Biotechnology, Clinical Research & Trials, Computing & Technology, Diagnostics & Hospital Laboratory, Drug Discovery & Development, General Laboratory, Healthcare, Omics & Genetics, Pharma
GenomSys, a software company which develops technology for efficient processing and sharing of DNA data, announces a collaboration with SysMeta IT, a digital services company catering to medical clinics and labs in Switzerland and editor of Tangerine Medical and...
by Life Science Newswire | Nov 25, 2019 | Clinical Research & Trials, Corporate, Finance & Investor, Healthcare, Manufacturing, Pharma
The global pharmaceutical company and service partner Inceptua Group (previously Multipharma GmbH) and Bendalis GmbH – German manufacturer of generic oncology drugs and special therapeutic agents, today announce the signing of an exclusive clinical trial supply...
Recent Comments